Methanex Corp (MX.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Methanex Corp (MX.TO)

72.82

-2.49 (3.31%)

as of Aug 5, 2026, 8:00:00 pm Market Open.

101 watching

Investor Insights

Aug 5, 2026, 12:00 am

This summary was created by AI, based on 3 opinions in the last 12 months.

Methanex Corp (MX-T) has garnered mixed yet informative perspectives from several experts. One trader notes a successful trading history, highlighting a buy at around $50 and a sell at approximately $75, indicating a cautious approach for future buying unless a breakout occurs. Another expert points out the company's strong performance in terms of RSI and suggests that the ongoing geopolitical tensions, particularly the US-Iran war, will benefit the fertilizer and chemicals sector, with an optimistic price target of $89.31. A third review mentions a recent pullback after a breakout, identifying old support levels around $55-56. This expert believes there is potential for further gains if these levels hold, combining both technical and fundamental insights favorably towards Methanex. Overall, the sentiment reflects a blend of caution and optimism, with the potential for further price appreciation contingent on market developments.

Consensus

Positive

Valuation

Fair Value

Similar

Nutrien, NTR

TOP PICK

A global leader. Their EBITDA should bottom in Q1. They started their Chilean plant on time and on budget. They're buying back 5% of its share. It's trading below its historic multiple. It's a play on Brent oil and global growth. A tailwind is Iranian curtailment. You can hold this for a long time. But it's a very cyclical name. (Analysts’ price target is $82.91)

PAST TOP PICK

(A Top Pick Mar 21/18, Down 1%) It produces a fuel octane booster. He sold out on a gain of 9.5%. It does not rank as high today as sales are increasing but earnings are falling. Not a candidate for purchase today.

BUY

Good buying after the recent sell-off. Put a stop at $71 or at least reduce. Perhaps $10 upside. Likes it.

BUY

Pays 2.5%, 2% dividend. They continue to generate free cash flow to fund projects, yet do share buybacks. Good balance sheet. A fine name. They track Brent Oil. A good proxy on the global economy. A quality name. Hold and buy on weakness.

DON'T BUY

Had a change of heart about commodity companies. They don't have a lot of control over input price of oil. Terrific balance sheet, dividend increases. There are worse places to put your money, but he wants less cyclical choices with more pricing power. Yield is 2.49%.

HOLD

Still looks good. If you own, continue to hold, sees no reason to sell.

BUY

Nice long-term trend and has long, deep support at $80. Sharp increase since January is really stable.

WAIT

It's done well. It's broken above its rising trend since last-2016. Not seasonal now. Look for a base below $80. Wait.

WAIT

It's done well. It's broken above its rising trend since last-2016. Not seasonal now. Look for a base below $80. Wait.

BUY

Chemical stocks are cyclical and now behaving well. He likes it. The commodities group is performing well, benefitting from a stronger economy. MX should trade higher throughout 2018. But with cyclicals, buy them with they look cheap,
and sell when they look pricey.

BUY

Excellent company. The valuation justifies the business. Has access to low-cost gas. Well positioned company. All the fundamentals tick off for him.

COMMENT

The stock has done well. It's the world's largest producer of methanol, used to produce chemicals. She won't buy it here, but if she owned enough, she would probably take some profits here, and buy on a pullback--it has a choppy chart.

DON'T BUY

This is a really good free cash flow generator. There has been speculation of a takeout of Methanex, which is probably one of the reasons the stock price has performed so well lately.

TOP PICK

They are the largest player in terms of methanol production globally. They are diversified globally. It is in the top 4% in valuation. They have a 23% return on equity. A low payout ratio and a bit of a yield. They have been speculated to be a target for CF industries. (Analysts’ target: $82.18).

TOP PICK

This company has had a dramatic turnaround in their business, he says, and they do not own it yet. The payout ratio is only 12% and sales are up 45% on the year. ROE is now 27% from negative a year ago. Earnings are expected to be up 35%. Technical analysts suggest if it can break above $81 it can challenge $100 per share. Yield 2.2%. (Analysts’ price target is $81.51 )

Showing 76 to 90 of 409 entries

Most Recent Experts

Jim Cramer - Mad Money

CNBC

Jerome Hass

Lightwater Partners

Mike Vinokur, CFA, CMT, and CFP

Propellus Wealth Partners/iA Private Wealth

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

The Monthly Gems by Allan Tong

Stockchase

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Methanex Corp (MX.TO)